James C. Tsai
From Wikipedia, the free encyclopedia
James C. Tsai | |
|---|---|
 | |
| Born | 1963 (age 62–63) |
| Education | Amherst College, Stanford University School of Medicine, Owen Graduate School of Management at Vanderbilt University |
| Medical career | |
| Profession | Ophthalmologist |
| Institutions | Vanderbilt University School of Medicine, Harkness Eye Institute at Columbia University College of Physicians and Surgeons, Yale University School of Medicine, New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai |
| Sub-specialties | Glaucoma and glaucoma surgery |
| Website | James C. Tsai at Mount Sinai |
James C. Tsai is a physician and scientist who serves as president of the New York Eye and Ear Infirmary of Mount Sinai.[1][2][3] Tsai published the first taxonomy of medication adherence barriers in glaucoma, the first paper on isolated-check visual evoked potential technology for glaucoma patients,[4] and an early study of erythropoietin for neuroprotection in an animal model of glaucoma.
He is the Delafield-Rodgers Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and chair of the department of ophthalmology at the Mount Sinai Health System.
Tsai graduated from Phillips Exeter Academy in 1981, earned a B.A. in neuroscience from Amherst College in 1985,[5] an M.D. from Stanford University in 1989, and an M.B.A. from Vanderbilt University in 1998.[6] He completed an ophthalmology residency at the Doheny Eye Institute of the University of Southern California, followed by glaucoma fellowships at Bascom Palmer Eye Institute and at Moorfields Eye Hospital and the Institute of Ophthalmology in London.[7]
Early career positions include assistant professor and residency program director at Vanderbilt University School of Medicine, associate professor and director, department of ophthalmology, Edward S. Harkness Eye Institute, and Columbia University College of Physicians and Surgeons.[1][7][8]
Tsai then served as the inaugural Robert R. Young Professor of Ophthalmology and Visual Science and chair, department of ophthalmology and visual science, Yale University School of Medicine[9] and chief of ophthalmology, Yale-New Haven Hospital.[10]
Research
Tsai's research includes the identification of neuroprotective molecules that can shield the optic nerve from damage without lowering intraocular pressure, evaluation of medical adherence and surgical outcomes in patients with glaucoma, and development of advanced vision testing techniques.[11]
Other research includes the long-term safety and efficacy of the Ahmed shunt versus the Baerveldt shunt implant, optimizing and enhancing medication adherence in patients with glaucoma, and understanding the role of inflammation in the pathogenesis and treatment of glaucoma.[12][13][14][15]
